Navigation Links
FPR Specialty Pharmacy Hires Slomski To Lead Sales And Marketing; Moves To Next Phase In Cleveland Clinic Trials
Date:1/8/2014

VICTOR, N.Y., Jan. 8, 2014 /PRNewswire/ -- FPR Specialty Pharmacy, developer of Focused Pain Relief—custom transdermal creams for pain and inflammation—today announced the appointment of Douglas B. Slomski to the position of Vice President of Sales and Marketing.  Effective immediately, Slomski will be responsible for expanding the company's presence in existing markets, as well as opening new markets and launching products. The company also announced today that the Cleveland Clinic study for the treatment of knee pain using Diclofenac Cream 8% or 1% has moved to the next phase, with participant enrollment to begin in the first quarter of 2014.

Slomski brings to FPR Specialty Pharmacy a 25-year background in marketing life-science products and extensive expertise in medical sales management. He most recently served on the management team at ECA Medical Instruments, where he helped with the global unveiling of a line of surgical kitting products and oversaw a five-year branding and implementation program.  Known for his solutions-based approach, Slomski is a global expert at growing revenue and market share through end-to-end product management and targeted sales strategies. He is also credited with over 12 patents in medical devices, packaging and sterilization processing equipment.

"FPR Specialty Pharmacy has exciting and aggressive plans to move the company forward in 2014. Doug Slomski is a top talent in the industry and his knowledge will further strengthen our management team and our position to achieve our goals," said Billy Rue, CEO of FPR Specialty Pharmacy.

As part of its expansion efforts, FPR Specialty Pharmacy is engaging in the Cleveland Clinic study to measure the effectiveness of Diclofenac creams in treating knee pain.  This research will provide valuable insights for treating pain and inflammation in the knee.  "This is a hallmark study for our industry and we greatly value partnering with the Cleveland Clinic on this project," said Rue. 

ABOUT FPR SPECIALTY PHARMACY
FPR Specialty Pharmacy is an advanced traditional compounding pharmacy specializing in solutions for relief of pain and inflammation.  The company's leading product, Focused Pain Relief, is a custom compounded, prescription-based transdermal cream. FPR Specialty Pharmacy is located in Victor, New York.  Learn more at: www.focusedpainrelief.com or follow FPR Specialty Pharmacy on LinkedIn.


'/>"/>
SOURCE FPR Specialty Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Numotion Acquires Specialty Wheelchairs, LLC
2. Endo to Acquire Specialty Pharmaceutical Company NuPathe
3. New Physicians Survey: Most Drugstores Lack the Expertise and Capability to Provide Specialty Medications
4. Giant Eagle Expands Specialty Pharmacy with Acquisition, Bringing Treatment Expertise to Customers with Hepatitis C and Organ Transplant Conditions
5. Tampa Pharmacist Receives Specialty Pharmacy Certification Credential from SPCB
6. Centene Specialty Pharma Subsidiary Receives Full URAC Accreditation
7. CVS Caremark to Purchase Coram Infusion Business from Apria Healthcare, Expanding Specialty Pharmacy Offering
8. Student Residency Program Planned by the National Association of Specialty Pharmacy (NASP)
9. Global Markets For Specialty Surgical Wound Care Products In 2013: Surgical Sealants, Glues, Absorbable Hemostats, And Adhesion Prevention Products
10. Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials
11. Pan Foundation Convenes Dialogue Series On Issues Surrounding Access To Specialty Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Alkermes PLC ... AMAG ), IDEXX Laboratories Inc. (NASDAQ: IDXX ... Learn more about these stocks by accessing their free trade ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... To ... infrastructure. Most providers, however, are unsure how to move forward, given the need ... define a path forward tailored to an organization’s specific needs. , PYA Principal ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... SpiritQuest Sedona ... heart of West Sedona, surrounded by famous vortex sites: Cathedral Rock, Airport Mesa, and ... partner properties – the Lodge at Sedona as well as the Sedona Rouge, both ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... An ... may expose a possible link between head and neck cancer in individuals with unhealthy ... the study were evaluated based on whether they had gum disease, brushed their teeth ...
(Date:6/23/2016)... ... 23, 2016 , ... SyncDog, Inc. , the leading ... is featured in the current issue of Silicon Review magazine. Silicon ... technology solutions and features them in their magazine. The magazine allows top-level executives ...
Breaking Medicine News(10 mins):